The U.S. drug regulator on Aug. 23 granted full approval to the Pfizer Inc/BioNTech SE COVID-19 vaccine - the first to secure such Food and Drug Administration validation - prompting President Joe Biden to make a fresh pitch to vaccine skeptics to get the shot to fight the relentless pandemic.
A third dose of Pfizer Covid-19 vaccine has significantly improved protection from infection and serious illness among people aged 60 and older in Israel compared with those who received two shots, according to findings published by the Health Ministry and cited by Reuters. The full details of the study were not released.
As many as 5,643 doses of Pfizer, Moderna, AstraZeneca and Johnson & Johnson vaccine have been administered in the last 24 hours, of which 3,406 are the first dose and 2,237 the second dose, according to a report released Sunday by the National Committee of Coordination Activities against COVID-19 (CNCAV).
A new study out of the UK has shown that the effectiveness of the Pfizer/BioNTech vaccine is waning faster than others when up against a high viral load mutation of the coronavirus, like the Delta variant
As many as 15,260 vaccine doses from Pfizer, Moderna, AstraZeneca and Johnson&Johnson were administered in the last 24 hours, of which 10,831 represent the first dose, and 4,429 the second dose, according to a briefing sent on Wednesday by Romania's National COVID-19 Vaccination Coordination Committee (CNCAV).